RAPT Therapeutics, Inc. (RAPT:NASDAQ) soared at $29.47, representing a gain of 44.2%. The stock got featured on our News Catalysts scanner on Thu 31 Oct 19 at 11:15 AM in the 'PUBLIC OFFERING' category. From Mon 04 Nov 19, the stock recorded 50.00% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About RAPT Therapeutics, Inc. (RAPT:NASDAQ)
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Top 10 Gainers:
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 94.38%
- JanOne Inc. (JAN:NASDAQ), 54.51%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 51.61%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 44.25%
- CPI Card Group Inc. (PMTS:NASDAQ), 35.48%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 28.98%
- Ideanomics, Inc. (IDEX:NASDAQ), 27.14%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 24.55%
- The Medicines Company (MDCO:NASDAQ), 22.25%
- Neoleukin Therapeutics, Inc. (NLTX:NASDAQ), 22.19%